Fragment-Based Drug Discovery - Getting in Shape Doris Hafenbradl, Biofocus, speaking at Discovery Chemistry Congress 2012.
The Versatility of Fragment Screening Approaches and the Application of Fragment Binding Information in Durg Discovery Stefan Geschwindner, AstraZeneca, speaking at Discovery Chemistry Congress 2012.
Challenges of an Open Access Screening Platform in Academia Edgar Specker, Leibniz Institute of Molecular Pharmacology, speaking at European Lab Automation 2012
Microfabricated Cell-Culture Platforms to Study Cell Function and Drug Response in Engineered 2D and 3D Microenvironments Marcus Textor, ETH Zurich, speaking at Single Cell Analysis Europe 2012.
Current Challenges in Fragment-Based Drug Discovery Roderick E Hubbard, University of York, speaking at Discovery Chemistry Congress 2012.
Defence and Adaptation in Drug-Mediated Liver Toxicity Christopher Goldring, University of Liverpool, speaking at ADME & Predictive Toxicology Europe 2012
Integration of Parallel Systhesis, Compound Management and Screening in Support to the Itlian National Chemical Collection Center Alberto Bresciani, IRBM Science Park, speaking at European Lab Automation 2012
Capacitive Immunosensors – A Tool for Detection Where Sensitivity of Conventional ELISA is Not Sufficient Prof. Bo Mattiasson, Lund University, speaking at Advances in Biodetection and Biosensors 2012.
Rationalizing ADME in the Current Regulatory and Business Environment Robert Guttendorf, Aclairo Pharmaceutical Development Group, speaking at ADME & Predictive Toxicology Europe